February 25 - 28, 2015
Coming in 2015
A large prospective study found that among 89,918 women aged 50-79 years, bisphosphonate use was inversely associated with age-adjusted endometrial cancer risk, investigators reported. The study was...»
Poor baseline quality-of-life scores were not predictive of worse overall or recurrence-free survival, or of higher risk for adverse events following sublobar resection in high-risk surgical patients...»
PARIS – Health status should be evaluated when determining how best to treat an older man with prostate cancer, attendees at an international congress on anticancer treatment were told.
Survival rates overall for cancer patients are higher now than 20 years ago, though younger patients are faring significantly better than older ones for many types of cancer, according to...»
Managing Patients With Heavily Pretreated Metastatic Breast Cancer: Balancing Efficacy and Safety is a CME-Certified Supplement to Community Oncology®. This CME journal supplement is supported by an...»
Translational Genomic Research and the Treatment of Basal Cell Carcinoma is a CME-Certified Supplement to Skin & Allergy News(R). This journal supplement is supported by an educational grant from...»
Community Oncology Founding Editor Dr. Lee Schwartzberg, spoke with Dr. Joyce O'Shaughnessy at the Oncology Practice Summit in Las Vegas about emerging molecular biomarkers in breast cancer and...»
Community Oncology Editor Dr. Linda Bosserman spoke with Dr. Rowan Chlebowski at the Oncology Practice Summit in Las Vegas about the effect of diet and exercise on breast cancer patients.